GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Shiller PE Ratio

Lexagene Holdings (TSXV:LXG.H) Shiller PE Ratio : (As of Jun. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lexagene Holdings Shiller PE Ratio Historical Data

The historical data trend for Lexagene Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Shiller PE Ratio Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lexagene Holdings's Shiller PE Ratio

For the Medical Devices subindustry, Lexagene Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Shiller PE Ratio falls into.



Lexagene Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lexagene Holdings's E10 for the quarter that ended in Nov. 2022 is calculated as:

For example, Lexagene Holdings's adjusted earnings per share data for the three months ended in Nov. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=-0.013/125.6074*125.6074
=-0.013

Current CPI (Nov. 2022) = 125.6074.

Lexagene Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 -0.099 96.871 -0.128
201303 -0.428 98.209 -0.547
201306 -0.098 98.518 -0.125
201309 -0.010 98.790 -0.013
201312 -0.070 98.326 -0.089
201403 -0.095 99.695 -0.120
201406 0.071 100.560 0.089
201409 -0.030 100.428 -0.038
201412 -0.010 99.070 -0.013
201503 -0.009 99.621 -0.011
201506 -0.002 100.684 -0.002
201509 -0.003 100.392 -0.004
201512 -0.004 99.792 -0.005
201603 -0.012 100.470 -0.015
201606 -0.010 101.688 -0.012
201609 -0.010 101.861 -0.012
201702 -0.013 102.779 -0.016
201705 -0.014 103.256 -0.017
201708 -0.013 103.587 -0.016
201711 -0.038 104.072 -0.046
201802 -0.038 105.052 -0.045
201805 -0.039 106.148 -0.046
201808 -0.039 106.383 -0.046
201811 -0.040 106.338 -0.047
201902 -0.040 106.649 -0.047
201905 -0.040 108.048 -0.047
201908 -0.027 108.245 -0.031
201911 -0.053 108.519 -0.061
202002 -0.027 109.139 -0.031
202005 -0.042 108.175 -0.049
202008 -0.026 109.662 -0.030
202011 -0.039 109.793 -0.045
202102 -0.025 110.968 -0.028
202105 -0.024 113.576 -0.027
202108 -0.025 115.421 -0.027
202111 -0.025 117.269 -0.027
202202 -0.025 119.703 -0.026
202205 -0.026 123.323 -0.026
202208 -0.026 124.958 -0.026
202211 -0.013 125.607 -0.013

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lexagene Holdings  (TSXV:LXG.H) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lexagene Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (TSXV:LXG.H) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines